InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-05-02 00:00:00 ET · period of report 2024-05-01 · accession 0001477449-24-000107 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-02 2024-05-01 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH M - OptEx — +20.2K 96.5K +26% —
D 2024-05-02 2024-05-02 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH S - Sale+OE $12.69 -10.4K 86.1K -11% -$132.1K
D 2024-05-02 2024-05-01 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH M - OptEx $0.00 -20.2K 121.2K -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-01 M A 20,198 — 96,481 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2024-05-02 S D 10,411 $12.69 86,070 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2024-05-01 M D 20,198 $0.00 121,192 D — · — to — 20,198 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.